FAMILY MEDICINE 2021 Varsha Barnabas Farzana Daya Hawabibi Casmod Presented by AGGRESSION The aggressive patient usually presents as a danger to others to property and sometimes to themselves ID: 931561
Download Presentation The PPT/PDF document "MANAGEMENT OF THE AGGRESSIVE PATIENT" is the property of its rightful owner. Permission is granted to download and print the materials on this web site for personal, non-commercial use only, and to display it on your personal computer provided you do not modify the materials and that you retain all copyright notices contained in the materials. By downloading content from our website, you accept the terms of this agreement.
Slide1
MANAGEMENT OF THE AGGRESSIVE PATIENT
FAMILY MEDICINE 2021
Varsha Barnabas
Farzana Daya
Hawabibi Casmod
Presented by
Slide2AGGRESSION
The aggressive patient usually presents as a danger to others, to property and sometimes to themselvesAggression could occur in any setting (OPD,WARDS, HOSPITAL GROUNDS as well as COPC’S), therefore the policy applies to all these situations accordingly. It can also be either physical or verbal
“Feeling of anger or antipathy resulting in hostile or violent behaviour, readiness to attack or confront”
Slide3POSSIBLE CAUSES OF AGGRESSION
Delirium- hypoxaemia, metabolic, endocrine, post-ictal, sepsis, renal/organ failure :These cause clouding of consciousness, diminished comprehension, anxiety, perplexity, delusion of persecution and aggressionDementia-cerebral damage leading to decreased control and aggression
Medical
Antisocial & borderline personality disorderPsychosis Developmental disorders e.g. ID and autistic spectrum disorderHypomania or mania: the patient may become angry/hostile if obstructedSchizophrenia: patients may become aggressive due to delusional beliefs or in response to auditory hallucinations e.g. catatonic type: outbursts of over activity &/or aggressive behaviour seenSevere anxiety
Psychiatric
Slide4Alcohol, cannabis, mandrax, cocaine, methamphetamine & benzodiazepine withdrawal
Hypersensitive to reaction or insult
Poor frustration tolerance
Maladaptive coping skillsTrauma
PsychologicalSubstance use and withdrawal:POSSIBLE CAUSES OF AGGRESSION cont.
TBIsPTSD
Slide5POSITIVE PREDICTORS OF VIOLENCE
Male gender Prior history of violence Psychiatric illness Drug or ethanol abuse
Slide6PREVENTION POLICY
Never attempt to evaluate an armed patientCarefully search for any kind of offensive weapon( by security)Anticipate possible violence and treat such patients with understanding and gentlenessEnsure adequate security
Availability of more staffHave a clear exitRemain calm and non critical
Slide7BEFORE MANAGEMENT
Observe behaviour: often needs to be pre-emptive Try and gather as much information as possible on history: substance use, history of mental illness, sudden decline in function Visual examination of the patient , taking note of body language , clothing, eyes and speech (all of which can yield clues)
Try and take cognisance of any possible triggers (emotional/physical)
Slide8MANAGEMENT
Various avenues:Physical restraints
Seclusion Chemical restraints
Slide9MANAGEMENT – cont.
The rational for the use of seclusion is based on 3 therapeutic principles:
Containment
Restricted to a place where they are safe from harming themselves or others
IsolationAddresses the need for patients to distance themselves SeclusionProvides a decrease in sensory input for patients whose illness results in a heightened sensitivity to external stimulusPHYSICAL RESTRAINTSSECLUSION
Used as a last measure For the protection of the patient, other patients or health care worker Short duration as it can result in:Dehydration FracturesReduced perfusion Important to document Assign one team member to the pt’s head and each extremityBe humane but firmUse minimum force
Accomplish restraint quickly
Slide10Legality of physical restraint
Mental Healthcare Act no 17 of 2002
(Moosa and Jeenah, 2009; Policy Guidelines on Seclusion and Restraint of Mental Healthcare users 2012):Physical restraint is permissible Imperative to document details: duration, type of restraint and indication Patients who are likely to cause harm to themselves or others Only used when other methods of restraint fail (verbal) or if required to administer chemical/medical forms of restraintCertain conditions: not to be used any longer than absolutely necessary (ideally less than 4 hours for adults and a maximum of 2 hours for adolescents)When the desired effect is reached, it is no longer legal to continue physical restraintNever used as a form of punishmentAlways counsel family appropriately with regards to indications of use and duration Half hourly monitoring of patient condition Should not be used in children under the age of 12
Slide11BENZODIAZEPINES
PO DosingLorazepam 0.5- 2mg
Clonazepam 0.5-2 mgDiazepam 5-10 mgMidazolam 7.5-15 mg
IMI Dosing Lorazepam 0.5-2mgMidazolam 7.5-15 mg Clonazepam 0.5-2 mgANTI-PSYCHOTICS
Used in patients who are psychotic OR patients not responding to benzodiazepinesHaloperidol 2.5-5 mg IMIPromethazine(antihistamine) 25-50 mg IMI
POST SEDATION Reassess the situation Monitor vitalsSide effects Counsel family members if present CHEMICAL RESTRAINTS
Better than mechanical restraint as it maintains patient dignity
Rapid onset of action
Assess the patient
Age
Comorbidities
Cause of aggression
Monitor vitals
Single prescription
Always reassess between each prescription
Oral preparation
is
the
preferred route,
followed by intramuscular and then intravenous
Beware
of
drug side effects
Slide12Pharmacodynamics
Onset of action Duration of action
Benzos Diazepam (Valium)Rapid (within 15 minutes)1-3 days (LA)LorazepamRapid (within 15 minutes)10-20 hours (IMA)
Midazolam Most rapid 1-4 hours (SA)Clonazepam (Rivotril)Intermediate (15-30 minutes)1-2 days (IMA)Anti-psychoticsPromethazine (Phenergen)20-30 minutes 4-6 hours Haloperidol 30 seconds-1 minute4-6 hours
Slide13Side effects
Slide14Case study
A 28 year old male comes into the emergency department with his mother. The mother reports a 3 week history of “strange” behaviour: he has been talking to himself and starting arguments with his family.
When asked, the patient denies this accusation. He states that his mother is attempting to kick him out of the family home.
HX: no medical comorbidities, no history of acute illness O/E:General: the patient appears to be aggressive and uncooperativeVitals stableAll systems NADYou explain to the patient that in order to get him the right help, you need to take some bloods to do some tests. At this point, the patient starts screaming and threatening you. The other patients in the ED become concerned and he begins threatening other patients. The patient will not allow you to insert a drip nor will he allow you to approach him. How do you approach the situation?Be aware of environment/triggers of aggression in the patient e.g.: if you mention his mother, he suddenly becomes more angry. Avoid these triggersStay calm and do not shout at the patient, de-escalate the situation If communicating with him isn’t helping, consider asking for assistance with temporary physical restraint with the intention of sedating. Likely an IM method; inserting an IV line in this case may not be successful long-term Communicate calmly with his parent, explaining the need for restraint (or with anyone who may have escorted the patient)Sedate the patient and do necessary testing/sub-spec analysis Monitor patient’s general condition document clearly the need for sedation, counselling parent and duration of used method
Slide15Thank YOU
Slide16References
Buffett-Jerrott, S. E., & Stewart, S. H. (2002). Cognitive and sedative effects of benzodiazepine use.
Current pharmaceutical design
, 8(1), 45-58Lader, M. H., & Petursson, H. (1981). Benzodiazepine derivatives—side effects and dangers. Biological PsychiatryMoosa, M. Y. H., & Jeenah, F. Y. (2009). The use of restraints in psychiatric patients. South African Journal of Psychiatry, 15(3)POLICY GUIDELINES ON SECLUSION AND RESTRAINT OF MENTAL HEALTHCARE USERS (2012) Department of Health RSA, p 5-13Standard Treatment Guidelines and Essential Medicines list for South Africa (2018) Department of Health RSA, Primary Healthcare Level, sections 16.2-16.5
Vgontzas, A. N., Kales, A., & Bixler, E. O. (1995). Benzodiazepine side effects: role of pharmacokinetics and pharmacodynamics. Pharmacology, 51(4), 205-223